CDMO Activity Tracker: Lupin’s CDMO commissions oncology block in India; Cambrex, Axplora, Hovione expand operations

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Adenosine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 20 USDMF, 4 CEP/COS, 2 EU WC, 4 NDC API, 12 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

FINISHED DOSAGE FORMULATIONS

81 FDF Dossiers, 33 FDA Orange Book, 26 Europe, 4 Canada, 2 South Africa, 16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - 60MG/20ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - 90MG/30ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 11 Evonik, 6 Rochem International Inc, 14 SPI Pharma, 22 DKSH, 1 Pharm-RX Chemical, 3 Gangwal Healthcare, 2 Kewpie Corporation, 24 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 3 Pfanstiehl, 1 Capital Farma, 35 Kirsch Pharma, 4 ACG Worldwide, 11 Actylis, 2 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 20 BASF, 1 Bioplus Life Sciences, 2 BioSpectra, 5 CD Formulation, 2 Clariant, 16 Corel Pharma Chem, 2 Esteem Industries, 4 Finar, 16 Gangwal Chemicals, 2 Hayashibara, 3 Ideal Cures, 2 Ingredion Pharma Solutions, 9 Kerry, 1 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 6 Lubrizol Life Science Health, 12 Microlex e.U, 4 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 1 Novo Excipients, 4 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 31 Roquette, 28 Seppic, 3 Shandong Focus Biotechnology Co., Ltd, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 3 Sigachi Industries, 1 Symrise, 3 The Dow Chemical Company, 1 TopChem Pharmaceuticals, 2 Valens Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

87 Topical, 69 Solubilizers, 65 Thickeners and Stabilizers, 64 Parenteral, 46 Emulsifying Agents, 45 Coating Systems & Additives, 37 Fillers, Diluents & Binders, 26 Surfactant & Foaming Agents, 26 Taste Masking, 25 Film Formers & Plasticizers, 17 Rheology Modifiers, 16 Controlled & Modified Release, 14 Direct Compression, 12 Lubricants & Glidants, 11 API Stability Enhancers, 11 Co-Processed Excipients, 10 Granulation, 10 Chewable & Orodispersible Aids, 9 Empty Capsules, 7 Disintegrants & Superdisintegrants, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

17 News #PharmaBuzz

17 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 Regulatory FDF Prices, 3 Annual Reports

MARKET PLACE

22 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM, 5 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
29/11/2025	Archimica	Italy	EUTICALS SPA	22232	ADENOSINE	2008-11-25	Active	II	Complete	2013-09-21	2013-09-17
29/11/2025	Actylis	U.S.A	PHARMA-WALDHOF GMBH	7728	ADENOSINE	1988-10-25	Active	II	Complete	2013-06-08	2013-05-30

Adenosine

Adenosine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers

20 USDMF

4 CEP/COS

2 EU WC

4 NDC API

12 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

FINISHED DOSAGE FORMULATIONS

81 FDF Dossiers

33 FDA Orange Book

26 Europe

4 Canada

2 South Africa

16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - 60MG/20ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - 90MG/30ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

11 Evonik

6 Rochem International Inc

14 SPI Pharma

22 DKSH

1 Pharm-RX Chemical

3 Gangwal Healthcare

2 Kewpie Corporation

24 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

3 Pfanstiehl

1 Capital Farma

35 Kirsch Pharma

4 ACG Worldwide

11 Actylis

2 Aeon Procare

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

20 BASF

1 Bioplus Life Sciences

2 BioSpectra

5 CD Formulation

2 Clariant

16 Corel Pharma Chem

2 Esteem Industries

4 Finar

16 Gangwal Chemicals

2 Hayashibara

3 Ideal Cures

2 Ingredion Pharma Solutions

9 Kerry

1 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

6 Lubrizol Life Science Health

12 Microlex e.U

4 Nanjing Bold Chemical

2 Nippon Fine Chemical

1 Novo Excipients

4 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

31 Roquette

28 Seppic

3 Shandong Focus Biotechnology Co., Ltd

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

3 Sigachi Industries

1 Symrise

3 The Dow Chemical Company

1 TopChem Pharmaceuticals

2 Valens Pharmachem

INJECTABLE;INJECTION - 3MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - 60MG/20ML (3MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - 90MG/30ML (3MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons